NEUROSTAT

What this means for you

Registered since 04 Jun 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jun 2033: the §8 & §9 renewal).

Record

Serial number

85555773

Registration number

4347704

Mark type

Word mark

Filed

29 Feb 2012

Published for opposition

17 Jul 2012

Registered

04 Jun 2013

Current term from

04 Jun 2023

Next maintenance filing

§8 & §9 renewal, due by 04 Jun 2033 (grace period to 04 Dec 2033)

Attorney of record

Michael B. Chesal

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions

Owner

• PHARMING INTELLECTUAL PROPERTY B.V., LEIDEN, NL
• ABLIVA AB, LUND, SE
• NeuroVive Pharmaceutical AB, Lund, SE
• NeuroVive Pharmaceutical AB, Lund, SE
• NeuroVive Pharmaceutical AB, Lund, SE

Prosecution history

• 07 Jul 2026 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
• 18 Jun 2026 — NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
• 11 Jun 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 01 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 29 Mar 2026 — TEAS SECTION 7 REQUEST RECEIVED
• 14 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 14 Nov 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 14 Nov 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 08 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 15 May 2023 — TEAS SECTION 8 & 9 RECEIVED
• 26 Apr 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 04 Jun 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 18 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
• 18 Dec 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
• 06 Dec 2019 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED